Join to view full profile
1021 Morehead Medical DrSte ACharlotte, NC 28204
Phone+1 980-442-2000
Fax+1 704-355-5800
Dr. Fisher is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2005 - 2008
Icahn School of Medicine at Mount SinaiResidency, Internal Medicine/Pediatrics, 2001 - 2005
Medical University of South CarolinaClass of 2001
Certifications & Licensure
NC State Medical License 2008 - 2027
NY State Medical License 2002 - 2010
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2013-2014, 2017
- CMS Meaningful Use Stage 1 Certification MEDSEEK Empower, SymphonyCare, LLC, 2013-2014, 2017
- CMS Meaningful Use Stage 1 Certification MEDSEEK Empower, SymphonyCare, LLC, 2013-2014, 2017
Publications & Presentations
PubMed
- 6 citationsThe Genomic Landscape of Breast Cancer in Young and Older Women.Arielle L Heeke, Wei Sha, Rebecca Feldman, Julie Fisher, Lejla Hadzikadic-Gusic
Clinical Breast Cancer. 2024-10-01 - 129 citationsPembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) S...Ajjai Alva, Pam K. Mangat, Elizabeth Garrett-Mayer, Susan Halabi, Damien Hansra
Journal of Clinical Oncology. 2021-04-12 - 43 citationsCetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Pro...Julie Gottlieb Fisher, David Tait, Elizabeth Garrett-Mayer, Susan Halabi, Pam K. Mangat
Targeted Oncology. 2020-10-22
Press Mentions
Breast Cancer Diagnoses Rising Fastest Among Young WomenFebruary 4th, 2025- Integrative Oncology in Young Women with Breast CancerNovember 20th, 2022
In Latest Findings from ASCO TAPUR Study Trial Presented at AACR Annual MeetingAugust 19th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: